{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T16:01:52Z","timestamp":1772121712378,"version":"3.50.1"},"reference-count":85,"publisher":"Elsevier BV","issue":"40","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV008443"],"award-info":[{"award-number":["INV008443"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.vaccine.2021.08.034","type":"journal-article","created":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T03:50:25Z","timestamp":1628826625000},"page":"5891-5908","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Safety of components and platforms of COVID-19 vaccines considered for use in pregnancy: A rapid review"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5142-6122","authenticated-orcid":false,"given":"Agust\u00edn","family":"Ciapponi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4437-0073","authenticated-orcid":false,"given":"Ariel","family":"Bardach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agustina","family":"Mazzoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom\u00e1s","family":"Alconada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven A.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando J.","family":"Argento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2495-8040","authenticated-orcid":false,"given":"Jamile","family":"Ballivian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Bok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7111-5169","authenticated-orcid":false,"given":"Daniel","family":"Comand\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Erbelding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Goucher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beate","family":"Kampmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Karron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flor M.","family":"Munoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Carolina","family":"Palermo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward P.K.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Rodriguez Cairoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Santa Mar\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0057-6627","authenticated-orcid":false,"given":"Andy S.","family":"Stergachis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1984-5121","authenticated-orcid":false,"given":"Gerald","family":"Voss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9292-5059","authenticated-orcid":false,"given":"Xu","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5197-4134","authenticated-orcid":false,"given":"Natalia","family":"Zamora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabra","family":"Zaraa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mabel","family":"Berrueta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre M.","family":"Buekens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2021.08.034_b0005","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0140-6736(21)00617-6","article-title":"Access to COVID-19 vaccines: looking beyond COVAX","volume":"397","author":"Thex","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2021.08.034_b0010","doi-asserted-by":"crossref","DOI":"10.1111\/1468-0009.12503","article-title":"International Collaboration to Ensure Equitable Access to Vaccines for COVID-19: The ACT-Accelerator and the COVAX Facility","author":"Eccleston-Turner","year":"2021","journal-title":"Milbank Q"},{"key":"10.1016\/j.vaccine.2021.08.034_b0015","article-title":"Covax must go beyond proportional allocation of covid vaccines to ensure fair and equitable access","volume":"372","author":"Herzog","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2021.08.034_b0020","series-title":"medRxiv : the preprint server for health sciences","article-title":"COVID-19 vaccine response in pregnant and lactating women: a cohort study","author":"Gray","year":"2021"},{"key":"10.1016\/j.vaccine.2021.08.034_b0025","article-title":"Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis","volume":"370","author":"Allotey","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2021.08.034_b0030","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1515\/jpm-2020-0364","article-title":"COVID-19 during pregnancy: an overview of maternal characteristics, clinical symptoms, maternal and neonatal outcomes of 10,996 cases described in 15 countries","volume":"48","author":"Figueiro-Filho","year":"2020","journal-title":"J Perinat Med"},{"issue":"7","key":"10.1016\/j.vaccine.2021.08.034_b0035","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1111\/aogs.14118","article-title":"Maternal and perinatal outcomes related to COVID-19 and pregnancy: An overview of systematic reviews","volume":"100","author":"Vergara\u2010Merino","year":"2021","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"44","key":"10.1016\/j.vaccine.2021.08.034_b0040","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.15585\/mmwr.mm6944e3","article-title":"Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22-October 3, 2020","volume":"69","author":"Zambrano","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2021.08.034_b0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0253974","article-title":"COVID-19 and pregnancy: An umbrella review of clinical presentation, vertical transmission, and maternal and perinatal outcomes","volume":"16","author":"Ciapponi","year":"2021","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2021.08.034_b0050","doi-asserted-by":"crossref","unstructured":"Higgins J, Thomas J, Chandler J, MS. C, Li T, Page M, et al. Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated August 2019). In: Cochrane, editor. Cochrane, 2019.","DOI":"10.1002\/9781119536604"},{"key":"10.1016\/j.vaccine.2021.08.034_b0055","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jclinepi.2020.10.007","article-title":"Cochrane Rapid Reviews Methods Group offers evidence-informed guidance to conduct rapid reviews","volume":"130","author":"Garritty","year":"2021","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.vaccine.2021.08.034_b0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003583","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"18","author":"Page","year":"2021","journal-title":"PLoS Med"},{"issue":"4","key":"10.1016\/j.vaccine.2021.08.034_b0065","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/pds.851","article-title":"The Brighton Collaboration: enhancing comparability of vaccine safety data","volume":"12","author":"Kohl","year":"2003","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2021.08.034_b0070","unstructured":"CBER-FDA. In: Services USDoHaH, Administration F-FaD, Research C-CfBEa, editors. Guidance for Industry -Toxicity Grading Scale or Healthy Adult and Adolescent-Volunteers Enrolled in Preventive Vaccine Clinical Trials; 2007."},{"key":"10.1016\/j.vaccine.2021.08.034_b0075","unstructured":"EMA. ICH Topic E 2 A Clinical Safety Data Management: Definitions and Standards for Expedited Reporting EMA - European Medical Agency; 1995."},{"issue":"5","key":"10.1016\/j.vaccine.2021.08.034_b0080","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2165\/00124363-200418050-00001","article-title":"Medical Dictionary for Regulatory Activities (MedDRA)","volume":"18","author":"Fescharek","year":"2004","journal-title":"Int J Pharmaceut Med"},{"key":"10.1016\/j.vaccine.2021.08.034_b0085","unstructured":"Covidence systematic review software. Melbourne, Australia: Veritas Health Innovation."},{"key":"10.1016\/j.vaccine.2021.08.034_b0090","unstructured":"Higgins J, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. Cochrane; 2011."},{"key":"10.1016\/j.vaccine.2021.08.034_b0095","unstructured":"EPOC EPOoCCG. What study designs should be included in an EPOC review? EPOC Resources for review authors; 2017."},{"key":"10.1016\/j.vaccine.2021.08.034_b0100","unstructured":"NIH. Study Quality Assessment Tools. NIH National Heart L, and Blood Institute (NHLBI); 2020."},{"key":"10.1016\/j.vaccine.2021.08.034_b0105","unstructured":"Jan Brozek AO, Holger Sch\u00fcnemann. The GRADE Working Group GRADEpro. 3.2.2 for Windows. Updated March 2009; 2009."},{"issue":"38","key":"10.1016\/j.vaccine.2021.08.034_b0110","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.1016\/j.vaccine.2015.07.061","article-title":"Perinatal survival and health after maternal influenza A(H1N1)pdm09 vaccination: A cohort study of pregnancies stratified by trimester of vaccination","volume":"33","author":"Baum","year":"2015","journal-title":"Vaccine"},{"issue":"40","key":"10.1016\/j.vaccine.2021.08.034_b0115","doi-asserted-by":"crossref","first-page":"6215","DOI":"10.1016\/j.vaccine.2020.07.041","article-title":"Safety evaluation of adverse events following vaccination with Havrix, Engerix-B or Twinrix during pregnancy","volume":"38","author":"Celzo","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.08.034_b0120","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s40264-013-0030-1","article-title":"The PREGVAXGRIP study: a cohort study to assess foetal and neonatal consequences of in utero exposure to vaccination against A(H1N1)v2009 influenza","volume":"36","author":"Chavant","year":"2013","journal-title":"Drug Saf"},{"key":"10.1016\/j.vaccine.2021.08.034_b0125","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.2105\/AJPH.2011.300606","article-title":"H1N1 influenza vaccination during pregnancy and fetal and neonatal outcomes","volume":"102","author":"Fell","year":"2012","journal-title":"Am J Public Health"},{"issue":"6","key":"10.1016\/j.vaccine.2021.08.034_b0130","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.vaccine.2010.12.008","article-title":"Spontaneous reporting of adverse events following immunisation against pandemic influenza in Denmark November 2009-March 2010","volume":"29","author":"Folkenberg","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.08.034_b0135","first-page":"231","volume":"63","author":"Galindo Santana","year":"2011","journal-title":"Active surveillance of adverse effects of Pandemrix vaccine to prevent influenza A(H1N1) in Cuba Vigilancia activa de eventos adversos a la vacuna Pandemrixpara prevenir la influenza AH1N1 en Cuba"},{"issue":"47","key":"10.1016\/j.vaccine.2021.08.034_b0140","first-page":"6488","article-title":"Modeling maternal fetal RSV F vaccine induced antibody transfer in guinea pigs","volume":"33","author":"Glenn","year":"2015","journal-title":"Special Issue: Advancing maternal immunization programs through research in low and medium income countries"},{"issue":"41","key":"10.1016\/j.vaccine.2021.08.034_b0145","doi-asserted-by":"crossref","first-page":"6111","DOI":"10.1016\/j.vaccine.2018.08.074","article-title":"Uptake and safety of Hepatitis B vaccination during pregnancy: a Vaccine Safety Datalink study","volume":"36","author":"Groom","year":"2018","journal-title":"Vaccine"},{"issue":"44","key":"10.1016\/j.vaccine.2021.08.034_b0150","doi-asserted-by":"crossref","first-page":"6648","DOI":"10.1016\/j.vaccine.2019.09.043","article-title":"Uptake and safety of hepatitis A vaccination during pregnancy: A Vaccine Safety Datalink study","volume":"37","author":"Groom","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.08.034_b0155","first-page":"209","article-title":"Efficacy and safety of pandemic influenza vaccine in pregnancy","volume":"21","author":"Guo","year":"2010","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2021.08.034_b0160","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJMoa1207210","article-title":"Risk of fetal death after pandemic influenza virus infection or vaccination","volume":"368","author":"H\u00e5berg","year":"2013","journal-title":"New Engl J Med"},{"issue":"40","key":"10.1016\/j.vaccine.2021.08.034_b0165","doi-asserted-by":"crossref","first-page":"5530","DOI":"10.1016\/j.vaccine.2009.06.085","article-title":"The first safe inactivated equine influenza vaccine formulation adjuvanted with ISCOM-Matrix that closes the immunity gap","volume":"27","author":"Heldens","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.08.034_b0170","article-title":"Maternal vaccination against H1N1 influenza and offspring mortality: Population based cohort study and sibling design","volume":"351","author":"Jonas","year":"2015","journal-title":"BMJ (Online)"},{"key":"10.1016\/j.vaccine.2021.08.034_b0175","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1111\/j.1471-0528.2012.03470.x","article-title":"Vaccination against H1N1 influenza with Pandemrix\u00ae during pregnancy and delivery outcome: A Swedish register study","volume":"119","author":"K\u00e4ll\u00e9n","year":"2012","journal-title":"BJOG: Int J Obstetr Gynaecol"},{"key":"10.1016\/j.vaccine.2021.08.034_b0180","article-title":"Maternal immunization in argentina: The importance of a safety profile analysis. Open Forum","volume":"3","author":"Katz","year":"2016","journal-title":"Infect Dis"},{"key":"10.1016\/j.vaccine.2021.08.034_b0185","first-page":"469A","article-title":"Safety and immunogenicity of Heplisav-B in pregnancy","volume":"72","author":"Kushner","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.vaccine.2021.08.034_b0190","first-page":"908","article-title":"H1N1 influenza vaccine in pregnant women: French pharmacovigilance survey","volume":"33","author":"Lacroix","year":"2010","journal-title":"Drug Saf"},{"key":"10.1016\/j.vaccine.2021.08.034_b0195","unstructured":"L\u00e4kemedelsverket. L\u00e4kemedelsverket. Final summary of adverse drug reaction reports in Sweden with Pandemrix through October 2009-mid April 2010. June 2, 2010; 2010. Accessed 23 May 2011 from www.lakemedelsverket.se."},{"key":"10.1016\/j.vaccine.2021.08.034_b0200","first-page":"889","article-title":"Pilot swine flu vaccination active surveillance study: Final results","volume":"34","author":"Layton","year":"2011","journal-title":"Drug Saf"},{"key":"10.1016\/j.vaccine.2021.08.034_b0205","article-title":"Vaccination against influenza A(H1N1) virus is also safe during pregnancy","volume":"156","author":"Levi","year":"2012","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1016\/j.vaccine.2021.08.034_b0210","doi-asserted-by":"crossref","first-page":"848","DOI":"10.7326\/M16-0139","article-title":"Risk for congenital malformation with H1N1 influenza vaccine: a cohort study with sibling analysis","volume":"165","author":"Ludvigsson","year":"2016","journal-title":"Ann Inter Med"},{"issue":"7","key":"10.1016\/j.vaccine.2021.08.034_b0215","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s10654-013-9813-z","article-title":"Influenza H1N1 vaccination and adverse pregnancy outcome","volume":"28","author":"Ludvigsson","year":"2013","journal-title":"Eur J Epidemiol"},{"issue":"5","key":"10.1016\/j.vaccine.2021.08.034_b0220","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1365-2125.2011.04142.x","article-title":"Influenza H1N1 (swine flu) vaccination: a safety surveillance feasibility study using self-reporting of serious adverse events and pregnancy outcomes","volume":"73","author":"Mackenzie","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.vaccine.2021.08.034_b0225","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1056\/NEJMoa1908380","article-title":"Vaccination of pregnant women with respiratory syncytial virus vaccine and protection of their infants","volume":"383","author":"Madhi","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2021.08.034_b0230","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/cid\/ciy517","article-title":"The safety of influenza and pertussis vaccination in pregnancy in a cohort of Australian mother-infant pairs, 2012\u20132015: the FluMum study","volume":"68","author":"McHugh","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2021.08.034_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2013.12.036","article-title":"Reports to the vaccine adverse event reporting system after hepatitis a and hepatitis AB vaccines in pregnant women","volume":"210","author":"Moro","year":"2014","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.vaccine.2021.08.034_b0240","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.vaccine.2017.11.039","article-title":"Assessing the safety of hepatitis B vaccination during pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 1990\u20132016","volume":"36","author":"Moro","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.08.034_b0245","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1093\/infdis\/jiz390","article-title":"Safety and Immunogenicity of a Respiratory Syncytial Virus Fusion (F) Protein Nanoparticle Vaccine in Healthy Third-Trimester Pregnant Women and Their Infants","volume":"220","author":"Munoz","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2021.08.034_b0250","first-page":"209","article-title":"Vaccination against influenza a H1N1 and the risk of birth defects","volume":"19","author":"N\u00fa\u00f1ez Rojas","year":"2010","journal-title":"VacciMonitor"},{"issue":"30","key":"10.1016\/j.vaccine.2021.08.034_b0255","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1016\/j.vaccine.2012.04.081","article-title":"A(H1N1)v2009: a controlled observational prospective cohort study on vaccine safety in pregnancy","volume":"30","author":"Oppermann","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.08.034_b0260","first-page":"344","article-title":"influenza in pregnancy and risk of fetal death: cohort study in Denmark","volume":"2012","author":"Pasternak","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2021.08.034_b0265","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.2012.6131","article-title":"Risk of adverse fetal outcomes following administration of a pandemic influenza A(H1N1) vaccine during pregnancy","volume":"308","author":"Pasternak","year":"2012","journal-title":"JAMA J Am Med Assoc"},{"issue":"2","key":"10.1016\/j.vaccine.2021.08.034_b0270","doi-asserted-by":"crossref","first-page":"137.1","DOI":"10.1503\/cmaj.114-0006","article-title":"Peripartum outcomes: non-adjuvanted v. adjuvanted H1N1 vaccination","volume":"186","author":"Ray","year":"2014","journal-title":"CMAJ : Can Med Assoc J = journal de l'Association medicale canadienne"},{"key":"10.1016\/j.vaccine.2021.08.034_b0275","first-page":"13","article-title":"Maternal vaccinations in Australia-uptake, safety and impact","volume":"56","author":"Rega","year":"2016","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.vaccine.2021.08.034_b0280","first-page":"S58","article-title":"Swine flu vaccination in pregnancy and associated miscarriage risk","volume":"20","author":"Sammon","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2021.08.034_b0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051734","article-title":"Evaluating the Hazard of Foetal Death following H1N1 Influenza Vaccination; A Population Based Cohort Study in the UK GPRD","volume":"7","author":"Sammon","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2021.08.034_b0290","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-019-0138-0","article-title":"Safety and efficacy of ChAdOx1 RVF vaccine against Rift Valley fever in pregnant sheep and goats","volume":"4","author":"Stedman","year":"2019","journal-title":"npj Vaccines"},{"issue":"37","key":"10.1016\/j.vaccine.2021.08.034_b0295","doi-asserted-by":"crossref","first-page":"6358","DOI":"10.1016\/j.vaccine.2011.04.114","article-title":"Pregnancy and safety outcomes in women vaccinated with an AS03-adjuvanted split virion H1N1 (2009) pandemic influenza vaccine during pregnancy: a prospective cohort study","volume":"29","author":"Tavares","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.08.034_b0300","unstructured":"COVID-19 vaccine tracker. Vaccine Centre at the London School of Hygiene & Tropical Medicine; 2021. https:\/\/vac-lshtm.shinyapps.io\/ncov_vaccine_landscape\/ [Accessed May 20th 2021]."},{"key":"10.1016\/j.vaccine.2021.08.034_b0305","unstructured":"A Study of Ad26.COV2.S in Healthy Pregnant Participants (COVID-19); 2021. https:\/\/ClinicalTrials.gov\/show\/NCT04765384."},{"key":"10.1016\/j.vaccine.2021.08.034_b0310","unstructured":"Study to Evaluate the Safety, Tolerability, and Immunogenicity of SARS CoV-2 RNA Vaccine Candidate (BNT162b2) Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Older; 2021. https:\/\/ClinicalTrials.gov\/show\/NCT04754594."},{"key":"10.1016\/j.vaccine.2021.08.034_b0315","unstructured":"COVID-19: study to detect transfer of SARS-Cov-2 antibodies in breastmilk; 2021. https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2021-000893-27\/BE."},{"key":"10.1016\/j.vaccine.2021.08.034_b0320","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1093\/cid\/ciu915","article-title":"Maternal influenza immunization and birth outcomes of stillbirth and spontaneous abortion: a systematic review and meta-analysis","volume":"60","author":"Bratton","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2021.08.034_b0325","first-page":"CD001269","article-title":"Vaccines for preventing influenza in healthy adults","volume":"2","author":"Demicheli","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.vaccine.2021.08.034_b0330","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/1471-0528.12977","article-title":"Fetal death and preterm birth associated with maternal influenza vaccination: systematic review","volume":"122","author":"Fell","year":"2015","journal-title":"BJOG"},{"issue":"3","key":"10.1016\/j.vaccine.2021.08.034_b0335","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1080\/21645515.2018.1540807","article-title":"The safety of inactivated influenza vaccines in pregnancy for birth outcomes: a systematic review","volume":"15","author":"Giles","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2021.08.034_b0340","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220910","article-title":"Effects of maternal influenza vaccination on adverse birth outcomes: A systematic review and Bayesian meta-analysis","volume":"14","author":"Jeong","year":"2019","journal-title":"PLoS ONE"},{"issue":"49","key":"10.1016\/j.vaccine.2021.08.034_b0345","doi-asserted-by":"crossref","first-page":"9159","DOI":"10.1016\/j.vaccine.2011.08.008","article-title":"A systematic review of the evidence on the effectiveness and risks of inactivated influenza vaccines in different target groups","volume":"29","author":"Michiels","year":"2011","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2021.08.034_b0350","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1055\/s-0036-1586101","article-title":"The Effects of Influenza Vaccination during Pregnancy on Birth Outcomes: A Systematic Review and Meta-Analysis","volume":"33","author":"Nunes","year":"2016","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.vaccine.2021.08.034_b0355","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/AOG.0000000000001068","article-title":"Maternal Influenza Vaccination and Risk for Congenital Malformations: A Systematic Review and Meta-analysis","volume":"126","author":"Polyzos","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.vaccine.2021.08.034_b0360","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/ijgo.12394","article-title":"A systematic review and meta-analysis of fetal outcomes following the administration of influenza A\/H1N1 vaccination during pregnancy","volume":"141","author":"Zhang","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"10.1016\/j.vaccine.2021.08.034_b0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/11595670-000000000-00000","article-title":"Safety of hepatitis B, pneumococcal polysaccharide and meningococcal polysaccharide vaccines in pregnancy: a systematic review","volume":"35","author":"Makris","year":"2012","journal-title":"Drug Saf"},{"key":"10.1016\/j.vaccine.2021.08.034_b0370","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taz074","article-title":"Are all vaccines safe for the pregnant traveller? A systematic review and meta-analysis","volume":"27","author":"Nasser","year":"2020","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2021.08.034_b0375","doi-asserted-by":"crossref","DOI":"10.1097\/AOG.0000000000004438","article-title":"Antibody Response to Coronavirus Disease 2019 (COVID-19) Messenger RNA Vaccination in Pregnant Women and Transplacental Passage Into Cord Blood","author":"Prabhu","year":"2021","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2021.08.034_b0380","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciab266","article-title":"Efficient maternofetal transplacental transfer of anti- SARS-CoV-2 spike antibodies after antenatal SARS-CoV-2 BNT162b2 mRNA vaccination","author":"Rottenstreich","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2021.08.034_b0385","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2104983","article-title":"Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons","author":"Shimabukuro","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2021.08.034_b0390","article-title":"Role of maternal age and pregnancy history in risk of miscarriage: prospective register based study","volume":"364","author":"Magnus","year":"2019","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.vaccine.2021.08.034_b0395","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0022-3476(64)80188-8","article-title":"Congenital anomalies in the newborn infant, including minor variations. a study of 4,412 babies by surface examination for anomalies and buccal smear for sex chromatin","volume":"64","author":"Marden","year":"1964","journal-title":"J Pediatr"},{"issue":"4","key":"10.1016\/j.vaccine.2021.08.034_b0400","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0022-3476(87)80543-7","article-title":"Predictive value of minor anomalies. I. Association with major malformations","volume":"110","author":"Leppig","year":"1987","journal-title":"J Pediatr"},{"issue":"4","key":"10.1016\/j.vaccine.2021.08.034_b0405","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1056\/NEJM197607222950406","article-title":"Current concepts in genetics. Congenital malformations","volume":"295","author":"Holmes","year":"1976","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.vaccine.2021.08.034_b0410","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/bdr2.1589","article-title":"National population-based estimates for major birth defects, 2010\u20132014","volume":"111","author":"Mai","year":"2019","journal-title":"Birth Defects Res"},{"key":"10.1016\/j.vaccine.2021.08.034_b0415","article-title":"Etiology and clinical presentation of birth defects: population based study","volume":"357","author":"Feldkamp","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2021.08.034_b0420","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/S0140-6736(16)31575-6","article-title":"Global, regional, national, and selectedsubnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980\u20132015: asystematic analysis for the Global Burden of Disease Study 2015","volume":"388","author":"Wang","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2021.08.034_b0425","unstructured":"WHO. Status of COVID-19 Vaccines within WHO EUL\/PQ evaluation process; 2021. Accessed 12 May 2011 from: https:\/\/extranet.who.int\/pqweb\/sites\/default\/files\/documents\/Status_COVID_VAX_04May2021.pdf."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21010677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21010677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:02:14Z","timestamp":1759402934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21010677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":85,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0264410X21010677"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.08.034","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.06.03.21258283","asserted-by":"object"}]},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of components and platforms of COVID-19 vaccines considered for use in pregnancy: A rapid review","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.08.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}